Key Statistical Concepts in Clinical Trials for Pharma

Key Statistical Concepts In Clinical Trials for Pharma

By: J. Rick Turner

Write A Review

eBook | 29 December 2015

At a Glance

Format
ePUB

eBook

RRP $84.99

$76.99

or 4 interest-free payments of $19.25 with

Instant Digital Delivery to your Booktopia Reader App

This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.